24 Esophageal Cancer with Enteral Nutrition
pdf
keyboard_arrow_up
School
West Texas A&M University *
*We aren’t endorsed by this school
Course
MISC
Subject
Health Science
Date
Jun 11, 2024
Type
Pages
5
Uploaded by ProfSummer13850
4/2/2020
Clinical Case Studies for the Nutrition Care Process
https://openpage-ebooks.jblearning.com/wr/viewer.html?&oneTimePasscode=ST-4fb8b7be-b790-461d-9418-250b5aa1081c#book/fb090417-09af-4a6…
1/5
Clinical Case Studies for the Nutrition Care Process
ISBN 9781284157208
Case 24 Esophageal Cancer with Enteral Nutrition
Case 24
Esophageal Cancer with Enteral Nutrition
Learning Objectives
Upon completing this case study, readers will be able to:
1. Assess nutritional status in a patient with esophageal cancer.
2. Determine nutritional requirements of a patient with esophageal cancer.
3. Predict possible nutrition-related side effects of chemotherapy and radiation.
4. Calculate an enteral feeding regimen to meet nutritional needs.
5. Manage tube-feeding intolerance.
Background
Esophageal cancer is the eighth most common cancer worldwide and the sixth most
common cause of cancer deaths.
In the United States, the incidence had been climbing
but has now been gradually declining over the past decade. Risk factors for esophageal
cancer include male sex, smoking, gastroesophageal reflux, alcohol, obesity, and human
papilloma virus (HPV) infection. There is some evidence that processed meats increase risk;
vegetables, fruits, and physical activity are thought to decrease risk.
Esophageal cancer is
frequently not diagnosed until an advanced stage, and the overall 5-year survival rate is
approximately 20%.
Patients with esophageal cancer have been noted to have a higher percentage of
weight loss than patients with other types of cancer, and malnutrition is common,
occurring in up to 60% to 85% of patients.
Most patients present with dysphagia and
weight loss, symptoms that may not develop until after the disease has progressed to an
advanced stage.
Nutritional management is complicated by difficulty with oral intake due
to obstruction of the esophagus by the tumor.
Dysphagia; cancer cachexia; and the effects of chemotherapy, radiation, and surgery all
contribute to a unique challenge in maintaining adequate nutrition in this population.
Many patients are treated with chemotherapy and radiation prior to surgery. A high-
protein, high-calorie consistency modified diet should be attempted during this time, but
dysphagia and esophagitis caused by radiation may preclude adequate oral nutrition and
hydration. Esophageal stents or laser treatments are sometimes used to facilitate oral
intake prior to surgery or for palliation if surgery is not feasible.
Nutrition support may be needed during treatment both pre- and postoperatively.
While the enteral route is preferred to parenteral, preoperative tube feeding presents a
challenge with regard to enteral access. A laparoscopically placed jejunostomy is an option
that can be used early in treatment. Placement of a percutaneous endoscopic gastrostomy
1
2
3
,
4
5
3
,
4
,
6
–
8
3
,
5
4/2/2020
Clinical Case Studies for the Nutrition Care Process
https://openpage-ebooks.jblearning.com/wr/viewer.html?&oneTimePasscode=ST-4fb8b7be-b790-461d-9418-250b5aa1081c#book/fb090417-09af-4a6…
2/5
(PEG) tube or nasoenteric tube may not be possible due to obstruction of the esophagus
by the tumor. Many surgeons avoid the use of a PEG tube, since there is a risk of damage
to the stomach or its blood supply, which will eventually be used to create a neo-
esophagus during esophagectomy. Additionally, the potential exists for spreading tumor
cells during the PEG procedure.
If enteral access has not been obtained preoperatively,
a surgical jejunostomy tube is frequently placed during the esophagectomy procedure to
be used for postoperative nutrition support.
The role of the Registered Dietitian Nutritionist (RDN) in caring for patients with
esophageal cancer includes recognizing malnutrition, optimizing enteral nutrition,
managing gastrointestinal symptoms, monitoring nutritional adequacy, and guiding the
transition from enteral to oral feedings.
Case Description
The patient is a 56-year-old man with a history of gastroesophageal reflux disease,
Barrett’s esophagus, and a 30 pack/year history of smoking. He presents with a 3-month
history of coughing, sore throat, and progressive difficulty swallowing, first of solid foods
and more recently of liquids. He is currently experiencing nausea and early satiety. A
biopsy revealed adenocarcinoma of the distal esophagus and gastroesophageal junction.
Following chemotherapy with 5-fluorouracil and cisplatin, along with radiation, an
esophagectomy and j-tube placement are planned.
Nutritional Assessment Data
Anthropometric Measurements
Height: 5
′
8
″
Weight: 165 lbs
Usual weight: 185 lbs (3 months ago)
Biochemical Data and Test Results
Parameter
Value
Normal Range
(may vary by age, sex, and laboratory)
Sodium
140 mEq/L
135–147 mEq/L
Potassium
4.3 mEq/L
3.5–5.0 mEq/L
Chloride
100 mEq/L
98–106 mEq/L
CO
25 mEq/L
21–30 mEq/L
BUN
15 mg/dL
8–23 mg/dL
Creatinine
0.9 mg/dL
0.7–1.5 mg/dL
Glucose
89 mg/dL
70–110 mg/dL
Phosphorus
3.2 mg/dL
3.0–4.5 mg/dL
Albumin
2.9 mg/dL
3.5–5.5 g/dL
Prealbumin
8 mg/dL
16–40 mg/dL
6
,
8
,
9
3
*
2
4/2/2020
Clinical Case Studies for the Nutrition Care Process
https://openpage-ebooks.jblearning.com/wr/viewer.html?&oneTimePasscode=ST-4fb8b7be-b790-461d-9418-250b5aa1081c#book/fb090417-09af-4a6…
3/5
Parameter
Value
Normal Range
(may vary by age, sex, and laboratory)
Hemoglobin
13.8 mg/dL
14–18 g/dL (men)
12–16 g/dL (women)
Hematocrit
37%
38%–54% (men)
36%–47% (women)
Data from US Food and Drug Administration. Investigations Operations Manual
. Silver Spring, MD: US FDA; 2019. Accessed
August 19, 2019 from https://www.fda.gov/media/113432/download Morris JC. Dietitian’s Guide to Assessment and
Documentation
. Sudbury, MA: Jones & Bartlett Learning; 2011.
Modified barium swallow revealed functional oropharyngeal swallow, but moderate-to-
severe esophageal dysphagia with delayed movement of liquids in upper esophagus and
reflux into pharynx.
Nutrition-Focused Physical Findings
Appears weak and uncomfortable. Reports sore throat, cough, odynophagia, and
dysphagia. Subcutaneous fat stores appear adequate although he has some loose skin on
his arms. Deltoid muscle visibly wasted with squared shoulders and prominent acromion.
Trapezius and Pectoralis muscles reduced in size with prominent clavicle and scapula.
Quadriceps somewhat diminished. 1+ pedal edema.
Client History
He has a 30 pack/year history of smoking, and drinks 3 to 4 martinis on weekends.
Food/Nutrition-Related History
Prior to admission, he had been eating only small amounts of scrambled egg, oatmeal,
apple juice, canned peaches, and soup. Intake <50% of meals.
Medications
He is currently on intravenous fluids and a full liquid diet as tolerated, but only taking sips.
Medications include hydromorphone 4 mg q 6 hours and lansoprazole 30 mg.
Questions
1. What risk factors does this client have for esophageal cancer?
2. What is his ideal body weight, BMI, and percentage of both IBW and UBW? Comment on
his nutritional status. Is he malnourished, and if so, how would you classify his
malnutrition?
3. List the nutrition-related side effects of the chemotherapeutic agents that he will be
receiving. What are the possible nutrition-related side effects of radiation treatment?
4. Do you think he will be able to take sufficient nutrition by mouth during his
chemotherapy and radiation? Why or why not?
5. What specific dietary interventions could be used to attempt oral nutrition support
before the esophagectomy and surgical j-tube are performed?
*
*
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
- Access to all documents
- Unlimited textbook solutions
- 24/7 expert homework help
4/2/2020
Clinical Case Studies for the Nutrition Care Process
https://openpage-ebooks.jblearning.com/wr/viewer.html?&oneTimePasscode=ST-4fb8b7be-b790-461d-9418-250b5aa1081c#book/fb090417-09af-4a6…
4/5
6. He is now status post esophagectomy with gastric pull-up and feeding jejunostomy. He
is NPO and you are consulted for enteral feeding recommendations. Calculate his
energy, protein, and fluid needs, then recommend an enteral formula. Specify the
starting rate, how you would advance the feeding, and what your goal rate for formula
and flushes would be. Show your work.
7. He remains NPO, receiving full enteral feedings but reports having bloating and
fullness. How do you approach this situation? What do you recommend?
8. One week later, there are no signs of anastomotic leak, so an oral diet is started. Explain
what an anastomotic leak is. Since he has been cleared to eat, what type of diet should
be recommended?
9. How would you transition him from enteral to oral feedings?
10. Write a PES statement based on his initial presentation.
Case Study and Answer References
1. World Cancer Research Fund, American Institute for Cancer Research. Diet, Nutrition, Physical
Activity and Cancer: a global perspective. The third expert report
.
https://www.wcrf.org/dietandcancer
.
2. American Cancer Society. Key statistics for esophageal cancer.
https://www.cancer.org/cancer/esophagus-cancer/about/key-statistics.html
.
3. Fessler T, Havrila C. Nutrition support for esophageal cancer patients — strategies for meeting the
challenges while improving patient care. Today’s Dietit
. 2012;14(1):28-33.
4. Schizas D, Lidoriki I, Moris D, Liakakos T. Nutritional Management of Esophageal Cancer Patients
Dimitrios. In: Esophageal Abnormalities
. IntechOpen; 2017:89–116.
5. Reim D, Friess H. Feeding challenges in patients with esophageal and gastroesophageal cancers.
Gastrointest Tumors
. 2016;2(4):166–177.
6. Bower M, Jones W, Vessels B, Scoggins C, Martin R. Role of esophageal stents in the nutrition
support of patients with esophageal malignancy. Nutr Clin Pract
. 2010;25(3):244–249.
7. Martin RC 2nd, Cannon RM, Brown RE, et al. Evaluation of quality of life following placement of self-
expanding plastic stents as a bridge to surgery in patients receiving neoadjuvant therapy for
esophageal cancer. Oncologist
. 2014;19(3):259–265.
8. Kight CE. Nutrition considerations in esophagectomy patients. Nutr Clin Pract
. 2008;23(5):521–528.
9. Bower MR, Martin RC 2nd. Nutritional management during neoadjuvant therapy for esophageal
cancer. J Surg Oncol
. 2009;100(1):82–87.
10. White JV, Guenter P, Jensen G, et al. Convsensus statement: Academy of Nutrition and Dietetics
and American Society for Parenteral and Enteral Nutrition: characteristics recommended for the
identification and documentation of adult malnutrition (undernutrition). J Parenter Enteral Nutr
.
2012;36(3):275–283.
11. Kaul V. What Options Exist for Enteral Feeding in Preoperative Patients with Esophageal Cancer
Who Have Dysphagia? In: Adler D, ed. Curbside Consulation in GI Cancer for the
Gastroenterologist
. Slack, Inc.; 2011:7–10.
12. Bankhead R, Boullata J, Brantley S, et al. Enteral nutrition practice recommendations. J Parenter
Enteral Nutr
. 2009;33(2):122–167.
13. Parrish CR. Enteral feeding: eradicate barriers with root cause analysis and focused intervention.
Pract Gastroenterol
. 2019;184(February):14–32.
14. Lee ZY, Barakatun-Nisak MY, Noor Airini I, Heyland DK. Enhanced protein-energy provision via the
enteral route in critically ill patients (PEP uP Protocol): a review of evidence. Nutr Clin Pract
.
2016;31(1):68–79.
15. Kozeniecki M, Fritzshall R. Enteral nutrition for adults in the hospital setting. Nutr Clin Pract
.
2015;30(5):634–651.
16. Lord LM. Enteral access devices: types, function, care, and challenges. Nutr Clin Pract
.
2018;33(1):16–38.
17. Parrish CR, McCray S. Enteral feeding: dispelling myths. Pract Gastroenterol
. 2003;27(9):33–50.
18. Boullata JI, Carrera AL, Harvey L, et al. ASPEN safe practices for enteral nutrition therapy. J Parenter
Enteral Nutr
. 2017;41(1):15–103.
4/2/2020
Clinical Case Studies for the Nutrition Care Process
https://openpage-ebooks.jblearning.com/wr/viewer.html?&oneTimePasscode=ST-4fb8b7be-b790-461d-9418-250b5aa1081c#book/fb090417-09af-4a6…
5/5
19. Chen KN. Managing complications I: leaks, strictures, emptying, reflux, chylothorax. J Thorac Dis
.
2014;6(suppl 3):355–363.
20. Dent B, Griffin SM, Jones R, Wahed S, Immanuel A, Hayes N. Management and outcomes of
anastomotic leaks after oesophagectomy. Br J Surg
. 2016;103(8):1033–1038.
21. Academy of Nutrition and Dietetics. Nutrition Terminology Reference Manual (eNCPT): Dietetics
Language for Nutrition Care
. http://www.ncpro.org
. Accessed September 14, 2019.